GENE ONLINE|News &
Hepatitis B Virus
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
2023-07-28
Vir Biotech’s Investigational Antibody Therapy Shows Promise in 8-Patient Phase 1 HBV Trial
2021-01-27
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
